You are viewing the site in preview mode

Skip to main content

Table 1 Analysis of immunophenotype

From: Logistics of an advanced therapy medicinal product during COVID-19 pandemic in Italy: successful delivery of mesenchymal stromal cells in dry ice

% NL2 Dry ice
Batch 1 Batch 2 Batch 3 Mean ± SD Batch 1 Batch 2 Batch 3 Mean ± SD
7AAD− 95.5 95.2 95.3 95.3 ± 0.2 95.4 93.1 96.6 95.0 ± 1.8
CD105+ 99.9 99.7 99.9 99.8 ± 0.1 99.7 99.8 99.8 99.8 ± 0.1
CD90+ 99.7 99.7 99.8 99.7 ± 0.1 99.8 99.7 99.6 99.7 ± 0.1
CD73+ 100.0 100.0 100.0 100.0 ± 0.0 100.0 100.0 100.0 100.0 ≤ 0.0
CD45+  ≤ 2  ≤ 2  ≤ 2  ≤ 2  ≤ 2  ≤ 2  ≤ 2  ≤ 2
CD31+  ≤ 2  ≤ 2  ≤ 2  ≤ 2  ≤ 2  ≤ 2  ≤ 2  ≤ 2
CD34+  ≤ 2  ≤ 2  ≤ 2  ≤ 2  ≤ 2  ≤ 2  ≤ 2  ≤ 2
HLA DR+  ≤ 2  ≤ 2  ≤ 2  ≤ 2  ≤ 2  ≤ 2  ≤ 2  ≤ 2
  1. Antigen expression of UC-MSCs transferred from LN2 to 37 °C (left) and from dry ice to 37 °C (right). No significant differences were demonstrated
Back to article page

Journal of Translational Medicine

ISSN: 1479-5876

Contact us